FY2026 · ended Apr 30, 2026 · Revenue $3.03M, +13.7% YoY · Filed Jul 29, 2026
VitaNova Life Sciences Corporation (VNOV) files with the SEC under industry code 5130, Wholesale-Apparel, Piece Goods & Notions. In fiscal 2026, which ended Apr 30, 2026, it reported revenue of $3.0 million and a net loss of $37,304.
Revenue (TTM)
$3.24M
+22.0% vs year-ago TTM
Net income (TTM)
$-114,104
-113.3% vs year-ago TTM
Operating cash flow (TTM)
$557,561
-42.0% vs year-ago TTM
Free cash flow
—
EPS
$0.03
+200.0% vs prior year
Dividend per share
None
Shares outstanding
8.34M
-66.7% vs prior year
Net cash
—
Operating margin
-2.7%
FY 2027
Company profile
- Industry
- Wholesale-Apparel, Piece Goods & Notions (SIC 5130)
- Listed as
- VNOV (OTC)
- Fiscal year ends
- April 30
- Incorporated in
- NV
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1699709
- Former names
- YIJIA GROUP CORP. (until Jan 13, 2026); YIJIA GROUP CORP (until Jul 29, 2019); Soldino Group Corp (until Nov 26, 2018)
Other Wholesale-Apparel, Piece Goods & Notions companies
- Weyco Group Inc WEYS
- Stark Focus Group, Inc. SKFG
- Authentic Holdings, Inc. AHRO
- KEEMO Fashion Group Ltd KMFG
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Apr 30, 2026 |
FY 2025 Apr 30, 2025 |
FY 2024 Apr 30, 2024 |
FY 2023 Apr 30, 2023 |
FY 2022 Apr 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $3.0M | $2.7M | $570,694 | $38,000 | $120,000 |
| Operating income | $3,601 | $1.2M | $205,629 | -$24,227 | -$13,367 |
| Net income | -$37,304 | $850,746 | $140,865 | -$24,227 | $139,682 |
| Diluted EPS | — | $0.03 | $0.01 | $0.00 | $0.02 |
| Operating cash flow | $814,407 | $192,774 | -$375,880 | -$18,375 | $4,061 |
| Total assets | $2.4M | $2.3M | $1.2M | $8,728 | $23,103 |
| Total liabilities | $395,781 | $347,567 | $136,920 | $67,943 | $58,091 |
| Stockholders' equity | $2.1M | $1.9M | $1.1M | -$59,215 | -$34,988 |
| Cash and investments | $1.6M | $782,810 | $593,036 | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Sep 14, 2026 | Jul 31, 2026 |
| 10-K | Annual report | Jul 29, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 18, 2026 | Mar 12, 2026 |
| 10-Q | Quarterly report | Mar 16, 2026 | Jan 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2026 | Feb 19, 2026 |
| 8-K |
Current report
Other events
|
Jan 27, 2026 | Jan 27, 2026 |
All 97 VitaNova Life Sciences Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.